Board approves the recommendation of final dividend of Rs.0.80 per share having face value Rs.10.00 per share for the financial year ended 31st March 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Panchsheel Organics' Board of Directors met on May 30, 2025 and approved the audited financial results for Q4 and the financial year ended March 31, 2025, with the auditor issuing an unmodified opinion. The Board also recommended a final dividend of Rs. 0.80 per equity share on shares with a face value of Rs. 10, subject to shareholder approval at the upcoming AGM. Additionally, the Board approved related party transactions for FY2025-26 under omnibus approval and appointed M/s Talati and Associates as cost auditor and GMS & Co. as secretarial auditor for a five-year term from FY2025-26 to FY2029-30.
Shareholders will receive Rs. 0.80 per share as dividend once approved at the AGM, providing a modest income return; the announcement is routine and signals steady corporate governance with no major strategic change.